IP Library Granted Patent US 8,415,477
Granted Patent B2
US 8,415,477 · App. 13/149,392 · Granted Apr 9, 2013

Violet laser excitable dyes and their method of use

Inventors: Gayle Buller (Springfield, OR); Jixiang Liu (Eugene, OR); Stephen Yue (Eugene, OR); Jolene Bradford (Eugene, OR)
Assignee: Life Technologies Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,415,477
App. No.
13/149,392
Granted
Apr 9, 2013
Kind
B2
Abstract

The present invention provides dye compounds optimally excited at about 400 nm and have a Stokes shift of at least about 80 nm. These dyes find use in detection of analyte in a sample and the preparation of dye-conjugates.

Claims (34)

1. A compound according to the formula:

wherein

X is carbon;

Y is nitrogen;

Z is sulfur or oxygen;

R 1 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7-aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7-aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 1 comprises a reactive group, carrier molecule or solid support;

R 2 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7-aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7-aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 2 comprises a reactive group, carrier molecule or solid support;

R 3 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7-aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7-aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 3 comprises a reactive group, carrier molecule or solid support;

R 4 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7-aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7- aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 4 comprises a reactive group, carrier molecule or solid support;

R 5 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7- aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7- aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 5 comprises a reactive group, carrier molecule or solid support;

R 6 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7- aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7- aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 6 comprises a reactive group, carrier molecule or solid support;

R 7 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7- aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7- aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 7 comprises a reactive group, carrier molecule or solid support;

R 8 is hydrogen, alkyl, substituted alkyl, 5-, 6- or 7- aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7- aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 8 comprises a reactive group, carrier molecule or solid support;

R 9 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7- aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7-aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 9 comprises a reactive group, carrier molecule or solid support;

R 10 is hydrogen, alkyl, substituted alkyl, alkoxy, hydroxy, sulfo, halogen, amino, substituted amino, aldehyde, carboxylic acid, ester, azido, nitro, nitroso, cyano, thioether, 5-, 6- or 7- aromatic ring, 5-, 6- or 7- heteroaromatic ring, substituted 5-, 6- or 7- aromatic ring, or substituted 5-, 6- or 7- heteroaromatic ring; or R 10 comprises a reactive group, carrier molecule or solid support; or

a member selected from

R 1 in combination with R 2 ;

R 2 in combination with R 3 ;

R 3 in combination with R 4 ;

R 4 in combination with R 5 ;

R 6 in combination with R 7

R 7 in combination with R 8 ;

R 8 in combination with R 9 ; and

R 9 in combination with R 10 ;

together with the atoms to which they are joined, form a ring which is a 5-, 6- or 7-membered cycloalkyl, a substituted 5-, 6- or 7-membered cycloalkyl, a 5-, 6- or 7-membered heterocycloalkyl, a substituted 5-, 6- or 7-membered heterocycloalkyl, a 5-, 6- or 7-membered aryl, a substituted 5-, 6- or 7-membered aryl, a 5-, 6- or 7-membered heteroaryl, or a substituted 5-, 6- or 7-membered heteroaryl; and

wherein at least two of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 or R 9 comprises a sulfo group.

2. The compound according to claim 1 , wherein at least one of R 1 , R 2 , R 3 ,R 4 , R 5 , R 6 , R 7 , R 8 and R 9 comprises a reactive group, carrier molecule or solid support.

3. The compound according to claim 1 , wherein R 3 or R 8 comprises a reactive group, carrier molecule or solid support.

4. The compound according to claim 1 , wherein the reactive group comprises an acrylamide, an activated ester of a carboxylic acid, a carboxylic ester, an acyl azide, an acyl nitrile, an aldehyde, an alkyl halide, an anhydride, an aniline, an amine, an aryl halide, an azide, an aziridine, a boronate, a diazoalkane, a haloacetamide, a haloalkyl, a halotriazine, a hydrazine, an imido ester, an isocyanate, an isothiocyanate, a maleimide, a phosphoramidite, a reactive platinum complex, a silyl halide, a sulfonyl halide, or a thiol.

5. The compound according to claim 1 , wherein the reactive group comprises a carboxylic acid, succinimidyl ester of a carboxylic acid, hydrazide, amine or a maleimide.

6. The compound according to claim 1 , wherein the solid support comprises a microfluidic chip, a silicon chip, a microscope slide, a microplate well, silica gels, polymeric membranes, particles, derivatized plastic films, glass beads, cotton, plastic beads, alumina gels, polysaccharides, polyvinylchloride, polypropylene, polyethylene, nylon, latex bead, magnetic bead, paramagnetic bead, or superparamagnetic bead.

7. The compound according to claim 1 , wherein the solid support comprises Sepharose, poly(acrylate), polystyrene, poly(acrylamide), polyol, agarose, agar, cellulose, dextran, starch, FICOLL, heparin, glycogen, amylopectin, mannan, inulin, nitrocellulose, diazocellulose or starch.

8. The compound according to claim 1 , wherein the carrier molecule comprises a amino acid, a peptide, a protein, a polysaccharide, a nucleotide, a nucleoside, an oligonucleotide, a nucleic acid, a hapten, a psoralen, a drug, a hormone, a lipid, a lipid assembly, a synthetic polymer, a polymeric microparticle, a biological cell or a virus.

9. The compound according to claim 1 , wherein the carrier molecule comprises an antibody, an antibody fragment, an avidin, a streptavidin, a biotin, a blood component protein, a dextran, an enzyme, an enzyme inhibitor, a hormone, an IgG binding protein, a fluorescent protein, a growth factor, a lectin, a lipopolysaccharide, a microorganism, a metal binding protein, a metal chelating moiety, a non-biological microparticle, a peptide toxin, a phosphotidylserinebinding protein, a structural protein, a small-molecule drug, or a tyramide.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2012
From: BULLER, GAYLE; BRADFORD, JOLENE; YUE, STEPHEN; LIU, JIXIANG
To: LIFE TECHNOLOGIES CORPORATION
Reel/Frame 027601/0027 →
Continuity (4)
Continuation 11535458 · Sep 26, 2006
Provisional Application 60745599 · Apr 25, 2006
Provisional Application 60720690 · Sep 26, 2005
Related Publication 20120004397A1 · Jan 5, 2012